3906

    524742

    CAPLIPOINT

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    CAPLIN POINT LAB LTD. Share Price Today

    CAPLIN POINT LAB LTD. is currently trading at ₹2574.9, down by ₹10.9 from the previous close. The stock touched an intraday high of ₹2597.60 and a low of ₹2556.70 during the latest trading session. Over the past one year, CAPLIN POINT LAB LTD. has delivered a return of 25.05%, while the stock has gained 0.28% in the last one month.

    CAPLIN POINT LAB LTD. performance

    Today’s low Today’s high
    ₹ 2556.70 ₹ 2597.60
    ₹ 2574.10
    52 week low 52 week high
    ₹ 1500.30 ₹ 2699.00
    ₹ 2574.10
    Open Price ₹ 2580.00
    Prev. Close ₹ 2585.80
    Volume (Shares) 44432.00
    Total traded value ₹ 1143.72
    Upper Circuit ₹ 3102.90
    Lower Circuit ₹ 2068.70
    info

    Investment Returns

    Over 1 Month 0.28% Over 3 Months 37.90% Over 6 Months 46.38% Over 1 Year 25.05%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    CAPLIN POINT LAB LTD. fundamentals


    • Market cap (Cr) 19,566.20
    • P/E Ratio (TTM) 49.36
    • Beta 0.91
    • Book Value / share 269.76
    • Return on equity 21.97%
    • EPS (TTM) 52.17
    • Dividend yield 0.16%
    • Net profit/quarter (Cr) 109.50
    info icon alternate text
    • Market cap (Cr) 19,573.40
    • P/E Ratio (TTM) 49.36
    • Beta 0.83
    • Book Value / share 269.76
    • Return on equity 21.97%
    • EPS (TTM) 52.17
    • Dividend yield 0.16%
    • Net profit/quarter (Cr) 109.50
    info icon alternate text

    CAPLIN POINT LAB LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 191.36
    Operating Expense 114.72
    Net Profit 109.50
    Net Profit Margin (%) 57.22
    Earnings Per Share (EPS) 15.89
    EBITDA 144.67
    Effective Tax Rate (%) 20.49
    Particulars DEC 2025 (Values in Cr)
    Revenue 189.22
    Operating Expense 103.94
    Net Profit 87.28
    Net Profit Margin (%) 46.12
    Earnings Per Share (EPS) 11.49
    EBITDA 123.45
    Effective Tax Rate (%) 25.40
    Particulars SEP 2025 (Values in Cr)
    Revenue 175.18
    Operating Expense 105.39
    Net Profit 102.59
    Net Profit Margin (%) 58.56
    Earnings Per Share (EPS) 13.50
    EBITDA 135.07
    Effective Tax Rate (%) 20.47
    Particulars JUN 2025 (Values in Cr)
    Revenue 182.57
    Operating Expense 102.14
    Net Profit 85.89
    Net Profit Margin (%) 47.04
    Earnings Per Share (EPS) 11.30
    EBITDA 118.64
    Effective Tax Rate (%) 23.62
    Particulars MAR 2025 (Values in Cr)
    Revenue 173.61
    Operating Expense 104.70
    Net Profit 86.50
    Net Profit Margin (%) 49.82
    Earnings Per Share (EPS) 11.37
    EBITDA 116.29
    Effective Tax Rate (%) 21.47
    Particulars MAR 2026 (Values in Cr)
    Revenue 738.33
    Operating Expense 426.18
    Net Profit 396.58
    Net Profit Margin (%) 53.71
    Earnings Per Share (EPS) 52.17
    EBITDA 533.15
    Effective Tax Rate (%) 21.85
    Particulars MAR 2025 (Values in Cr)
    Revenue 752.41
    Operating Expense 445.33
    Net Profit 339.49
    Net Profit Margin (%) 45.12
    Earnings Per Share (EPS) 44.67
    EBITDA 466.56
    Effective Tax Rate (%) 23.13
    Particulars MAR 2024 (Values in Cr)
    Revenue 625.09
    Operating Expense 365.19
    Net Profit 283.71
    Net Profit Margin (%) 45.38
    Earnings Per Share (EPS) 37.36
    EBITDA 392.92
    Effective Tax Rate (%) 22.42
    Particulars MAR 2023 (Values in Cr)
    Revenue 528.61
    Operating Expense 334.46
    Net Profit 234.26
    Net Profit Margin (%) 44.31
    Earnings Per Share (EPS) 30.89
    EBITDA 318.91
    Effective Tax Rate (%) 20.08
    Particulars MAR 2022 (Values in Cr)
    Revenue 528.06
    Operating Expense 334.29
    Net Profit 187.87
    Net Profit Margin (%) 35.57
    Earnings Per Share (EPS) 24.82
    EBITDA 276.17
    Effective Tax Rate (%) 24.94
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 346.57
    ROE % 22.86
    ROCE % 26.03
    Total Debt to Total Equity 0.00
    EBITDA Margin 38.37
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 276.38
    ROE % 24.52
    ROCE % 26.67
    Total Debt to Total Equity 0.00
    EBITDA Margin 36.52
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 219.22
    ROE % 25.72
    ROCE % 26.56
    Total Debt to Total Equity 0.00
    EBITDA Margin 33.89
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 167.20
    ROE % 27.58
    ROCE % 28.38
    Total Debt to Total Equity 0.01
    EBITDA Margin 34.14
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 128.12
    ROE % 27.29
    ROCE % 28.40
    Total Debt to Total Equity 0.03
    EBITDA Margin 33.18
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 223.81
    ROE % 21.97
    ROCE % 28.50
    Total Debt to Total Equity 0.00
    EBITDA Margin 62.01
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 183.03
    ROE % 22.43
    ROCE % 28.84
    Total Debt to Total Equity 0.00
    EBITDA Margin 62.86
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 150.19
    ROE % 22.63
    ROCE % 28.24
    Total Debt to Total Equity 0.00
    EBITDA Margin 60.33
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 122.78
    ROE % 22.24
    ROCE % 29.50
    Total Debt to Total Equity 0.00
    EBITDA Margin 52.30
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 100.29
    ROE % 23.00
    ROCE % 30.68
    Total Debt to Total Equity 0.00
    EBITDA Margin 48.18
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 591.41
    Total Assets 3207.85
    Total Liabilities 3207.85
    Total Equity 2886.39
    Share Outstanding 7
    Price to Book Ratio 8.95
    Return on Assets (%) 16.71
    Return on Capital (%) 18.58
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 552.74
    Total Assets 2698.12
    Total Liabilities 2698.12
    Total Equity 2346.83
    Share Outstanding 7
    Price to Book Ratio 7.20
    Return on Assets (%) 16.94
    Return on Capital (%) 19.47
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 493.48
    Total Assets 2191.40
    Total Liabilities 2191.40
    Total Equity 1907.27
    Share Outstanding 7
    Price to Book Ratio 3.97
    Return on Assets (%) 17.16
    Return on Capital (%) 19.69
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 462.99
    Total Assets 1736.32
    Total Liabilities 1736.32
    Total Equity 1509.88
    Share Outstanding 7
    Price to Book Ratio 5.54
    Return on Assets (%) 17.26
    Return on Capital (%) 19.85
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 438.33
    Total Assets 1363.61
    Total Liabilities 1363.61
    Total Equity 1203.37
    Share Outstanding 7
    Price to Book Ratio 4.03
    Return on Assets (%) 17.76
    Return on Capital (%) 19.85
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 214.71
    Total Assets 1814.48
    Total Liabilities 1814.48
    Total Equity 1700.93
    Share Outstanding 7
    Price to Book Ratio 8.95
    Return on Assets (%) 18.71
    Return on Capital (%) 19.96
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 215.78
    Total Assets 1522.31
    Total Liabilities 1522.31
    Total Equity 1390.15
    Share Outstanding 7
    Price to Book Ratio 7.20
    Return on Assets (%) 18.63
    Return on Capital (%) 20.41
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 271.38
    Total Assets 1303.18
    Total Liabilities 1303.18
    Total Equity 1139.91
    Share Outstanding 7
    Price to Book Ratio 3.97
    Return on Assets (%) 17.97
    Return on Capital (%) 20.55
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 316.08
    Total Assets 1054.16
    Total Liabilities 1054.16
    Total Equity 930.65
    Share Outstanding 7
    Price to Book Ratio 5.54
    Return on Assets (%) 17.82
    Return on Capital (%) 20.19
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 345.49
    Total Assets 860.99
    Total Liabilities 860.99
    Total Equity 758.67
    Share Outstanding 7
    Price to Book Ratio 4.03
    Return on Assets (%) 18.14
    Return on Capital (%) 20.59
    Particulars MAR 2025 (Values in Cr)
    Net Income 676.78
    Cash from Operations 560.01
    Cash from Investing -334.73
    Cash from Financing -38.32
    Net change in Cash 59.32
    Free Cash Flow 751.53
    Particulars MAR 2024 (Values in Cr)
    Net Income 564.43
    Cash from Operations 427.39
    Cash from Investing -320.04
    Cash from Financing -38.07
    Net change in Cash -39.72
    Free Cash Flow 573.21
    Particulars MAR 2023 (Values in Cr)
    Net Income 451.35
    Cash from Operations 359.37
    Cash from Investing -217.58
    Cash from Financing -28.17
    Net change in Cash 25.62
    Free Cash Flow 552.84
    Particulars MAR 2022 (Values in Cr)
    Net Income 385.82
    Cash from Operations 418.23
    Cash from Investing -376.77
    Cash from Financing -40.68
    Net change in Cash -80.72
    Free Cash Flow 509.41
    Particulars MAR 2021 (Values in Cr)
    Net Income 313.62
    Cash from Operations 334.75
    Cash from Investing -29.44
    Cash from Financing -23.98
    Net change in Cash 215.19
    Free Cash Flow 408.08
    Particulars MAR 2025 (Values in Cr)
    Net Income 441.67
    Cash from Operations 299.71
    Cash from Investing -140.20
    Cash from Financing -38.10
    Net change in Cash 17.57
    Free Cash Flow 356.27
    Particulars MAR 2024 (Values in Cr)
    Net Income 365.74
    Cash from Operations 198.10
    Cash from Investing -118.94
    Cash from Financing -34.26
    Net change in Cash -42.19
    Free Cash Flow 221.17
    Particulars MAR 2023 (Values in Cr)
    Net Income 293.15
    Cash from Operations 222.14
    Cash from Investing -86.67
    Cash from Financing -30.42
    Net change in Cash 40.01
    Free Cash Flow 280.77
    Particulars MAR 2022 (Values in Cr)
    Net Income 250.31
    Cash from Operations 292.95
    Cash from Investing -275.93
    Cash from Financing -22.76
    Net change in Cash -67.72
    Free Cash Flow 300.17
    Particulars MAR 2021 (Values in Cr)
    Net Income 209.94
    Cash from Operations 349.54
    Cash from Investing -3.71
    Cash from Financing -3.47
    Net change in Cash 287.46
    Free Cash Flow 392.09
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 19.35 2.25 357.34 23.12 47.39
    BLISS GVS PHARMA LTD 477.10 38.41 4.24 5068.90 118.35 552.90
    CIPLA LTD. 1472.00 33.23 3.45 118914.83 1165.55 1672.20
    FERMENTA BIOTECH LTD. 559.55 26.17 4.05 1646.81 256.40 568.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 46.63 32.61 6.00 357.34 23.12 47.39
    AMRUTAJAN HEALTH LTD 522.95 23.44 4.08 1511.88 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8188.15 107.01 23.45 20470.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 477.10 51.63 4.38 5068.90 118.35 552.90

    CAPLIN POINT LAB LTD. shareholding pattern

    Holding
    21.18%
    70.57%
    5.75%
    2.49%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    CAPLIN POINT LAB LTD. Technicals Summary

    2574.10 -0.45 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 2567.90
    • 26 Days 2540.40
    • 10 Days 2566.00
    • 50 Days 2431.70
    • 12 Days 2565.90
    • 100 Days 2246.60
    • 20 Days 2557.40
    • 200 Days 2106.40
    2575.90 PIVOT
    First Support 2551.90 First Resistance 2609.80 Second Support 2518.00 Second Resistance 2633.80 Third Support 2494.00 Third Resistance 2667.70
    RSI 53.41 ADX 11.47 MACD 25.51 Williams % R -42.11 Commodity Channel Index (CCI) -10.20
    Date 2026-08-07 Week 25732.00 Same Day 22594.00 Month 42859.00
    1 Year 0.91 3 Year 1.02
    Over 1 Month
    0.28% down
    Over 1 Year
    25.05% down
    Over 3 Months
    37.90% down
    Over 3 Years
    42.15% down
    Over 6 Months
    46.38% down
    Over 5 Years
    22.98% down

    CAPLIN POINT LAB LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    29 May 2026 4.0 Interim 30 May 2026 Equity shares
    12 Sep 2025 3.0 Final 12 Sep 2025 Equity shares
    30 May 2025 3.0 Interim 30 May 2025 Equity shares
    23 Sep 2024 2.5 Final 23 Sep 2024 Equity shares
    31 May 2024 2.5 Interim 31 May 2024 Equity shares
    14 Sep 2023 2.5 Final 14 Sep 2023 Equity shares
    09 Jun 2023 2.0 Interim 09 Jun 2023 Equity shares
    21 Sep 2022 2.0 Final 22 Sep 2022 Equity shares
    23 May 2022 2.0 Interim 24 May 2022 Equity shares
    20 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
    18 May 2021 1.5 Interim 19 May 2021 Equity shares
    21 Sep 2020 0.4 Final 23 Sep 2020 Equity shares
    12 Mar 2020 2.1 Interim 13 Mar 2020 Equity shares
    04 Sep 2019 2.2 Final 06 Sep 2019 Equity shares
    18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
    07 Sep 2017 1.5 Final 09 Sep 2017 Equity shares
    01 Sep 2016 3.5 Final 03 Sep 2016 Equity shares
    15 Feb 2016 2.5 Interim 16 Feb 2016 Equity shares
    29 Oct 2015 5.0 Final 31 Oct 2015 Equity shares
    11 Dec 2014 4.0 Final 13 Dec 2014 Equity shares
    19 Dec 2013 2.5 Final 21 Dec 2013 Equity shares
    11 Dec 2012 2.0 Final 13 Dec 2012 Equity shares
    12 Dec 2011 1.5 Final 24 Dec 2011 Equity shares
    09 Dec 2010 1.0 Final 22 Dec 2010 Equity shares
    Ex-Date Old FV NEW FV Record Date
    19 Oct 2016 10.0 2.0 20 Oct 2016
    Dividend date Dividend amount Dividend type Record date Instrument type
    29 May 2026 4.0 Interim 30 May 2026 Equity shares
    12 Sep 2025 3.0 Final 12 Sep 2025 Equity shares
    30 May 2025 3.0 Interim 30 May 2025 Equity shares
    23 Sep 2024 2.5 Final 23 Sep 2024 Equity shares
    31 May 2024 2.5 Interim 31 May 2024 Equity shares
    14 Sep 2023 2.5 Final 14 Sep 2023 Equity shares
    09 Jun 2023 2.0 Interim 09 Jun 2023 Equity shares
    21 Sep 2022 2.0 Final 22 Sep 2022 Equity shares
    23 May 2022 2.0 Interim 24 May 2022 Equity shares
    20 Sep 2021 1.5 Final 21 Sep 2021 Equity shares
    18 May 2021 1.5 Interim 19 May 2021 Equity shares
    21 Sep 2020 0.4 Final 23 Sep 2020 Equity shares
    12 Mar 2020 2.1 Interim 13 Mar 2020 Equity shares
    04 Sep 2019 2.2 Final 06 Sep 2019 Equity shares
    18 Sep 2018 2.0 Final 20 Sep 2018 Equity shares
    07 Sep 2017 1.5 Final 09 Sep 2017 Equity shares
    01 Sep 2016 3.5 Final 03 Sep 2016 Equity shares
    15 Feb 2016 2.5 Interim 16 Feb 2016 Equity shares
    29 Oct 2015 5.0 Final 31 Oct 2015 Equity shares
    11 Dec 2014 4.0 Final 13 Dec 2014 Equity shares
    19 Dec 2013 2.5 Final 21 Dec 2013 Equity shares
    11 Dec 2012 2.0 Final 13 Dec 2012 Equity shares
    12 Dec 2011 1.5 Final 24 Dec 2011 Equity shares
    09 Dec 2010 1.0 Final 22 Dec 2010 Equity shares
    Ex-Date Old FV NEW FV Record Date
    19 Oct 2016 10.0 2.0 20 Oct 2016

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Caplin Point Laboratories Ltd?

    Answer Field

    Caplin Point Laboratories Ltd share price is for NSE ₹ 2,574.90 & for BSE ₹ 2,577.15 as on Aug 07 2026 03:29 PM.

    What is the Market Cap of Caplin Point Laboratories Ltd Share?

    Answer Field

    The market cap of Caplin Point Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 07 2026 03:29 PM.

    What is the 52 Week High and Low of Caplin Point Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Caplin Point Laboratories Ltd for NSE is ₹ 2,699.00 and ₹ 1,500.30 and for BSE is ₹ 2,700.00 and ₹ 1,502.45.

    What is 1 year return for Caplin Point Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been 25.05%.

    What is the P/E Ratio of Caplin Point Laboratories Ltd Share?

    Answer Field

    As on Aug 07 2026 03:29 PM the price-to-earnings (PE) ratio for Caplin Point Laboratories Ltd share is 49.36.

    What is the PB ratio of Caplin Point Laboratories Ltd Share?

    Answer Field

    As on Aug 07 2026 03:29 PM, the price-to-book (PB) ratio for Caplin Point Laboratories Ltd share is 269.76.

    How to Buy Caplin Point Laboratories Ltd Share?

    Answer Field

    You can trade in Caplin Point Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Caplin Point Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Caplin Point Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Caplin Point Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |